263 related articles for article (PubMed ID: 22155903)
21. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
Grinsztejn B; Veloso VG; Levi JE; Velasque L; Luz PM; Friedman RK; Andrade AC; Moreira RI; Russomano F; Pilotto JH; Bastos FI; Palefsky J
Int J Infect Dis; 2009 Jan; 13(1):72-80. PubMed ID: 18632296
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
23. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
25. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men.
Vajdic CM; van Leeuwen MT; Jin F; Prestage G; Medley G; Hillman RJ; Stevens MP; Botes LP; Zablotska I; Tabrizi SN; Grulich AE
Sex Transm Infect; 2009 Sep; 85(5):330-5. PubMed ID: 19342375
[TBL] [Abstract][Full Text] [Related]
26. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
28. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area.
Núñez-Troconis J; Delgado M; González J; Mindiola R; Velásquez J; Conde B; Whitby D; Munroe DJ
Invest Clin; 2009 Jun; 50(2):203-12. PubMed ID: 19662815
[TBL] [Abstract][Full Text] [Related]
30. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
[TBL] [Abstract][Full Text] [Related]
31. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
[TBL] [Abstract][Full Text] [Related]
32. Sexual behavior and high-risk human papillomavirus in 15- to 22-year-old Lithuanian women.
Bumbuliene Z; Alisauskas J
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):511-3. PubMed ID: 22149963
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy).
Masia G; Mazzoleni AP; Contu G; Laconi S; Minerba L; Montixi S; Montis F; Onano A; Porcedda E; Coppola RC
Vaccine; 2009 May; 27 Suppl 1():A11-6. PubMed ID: 19480954
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus incidence and risk factors among Mexican female college students.
Sánchez-Alemán MA; Uribe-Salas FJ; Lazcano-Ponce EC; Conde-Glez CJ
Sex Transm Dis; 2011 Apr; 38(4):275-8. PubMed ID: 21124259
[TBL] [Abstract][Full Text] [Related]
35. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.
Kilmarx PH; van de Wijgert JH; Chaikummao S; Jones HE; Limpakarnjanarat K; Friedland BA; Karon JM; Manopaiboon C; Srivirojana N; Yanpaisarn S; Supawitkul S; Young NL; Mock PA; Blanchard K; Mastro TD
J Acquir Immune Defic Syndr; 2006 Nov; 43(3):327-34. PubMed ID: 16980907
[TBL] [Abstract][Full Text] [Related]
36. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
37. Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.
Sawaya GF; Chirenje MZ; Magure MT; Tuveson JL; Ma Y; Shiboski SC; Da Costa MM; Palefsky JM; Moscicki AB; Mutasa RM; Chipato T; Smith-McCune KK
Obstet Gynecol; 2008 Nov; 112(5):990-7. PubMed ID: 18978097
[TBL] [Abstract][Full Text] [Related]
38. Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report.
Joshi SN; Dutta S; Kumar BK; Katti U; Kulkarni S; Risbud A; Mehendale S
Sex Transm Infect; 2008 Oct; 84(5):343-7. PubMed ID: 18426844
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa.
Taku O; Businge CB; Mdaka ML; Phohlo K; Basera W; Garcia-Jardon M; Meiring TL; Gyllensten U; Williamson AL; Mbulawa ZZA
Int J Infect Dis; 2020 Jun; 95():176-182. PubMed ID: 32114194
[TBL] [Abstract][Full Text] [Related]
40. Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa.
van de Wijgert J; Jones H; Pistorius A; de Kock A; Sebola M; Friedland B; Hoosen A; Coetzee N
SAHARA J; 2005 Nov; 2(3):311-9. PubMed ID: 17600973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
